Alzchem Group Ag · XETR:ACT
Alzchem — Q4 2025 Earnings Presentation
41 slides from Alzchem's earnings presentation, Feb 27, 2026
Slide 1: Q4 2025 Company Presentation
Q4 2025 COMPANY PRESENTATION Andreas Niedermaier, CEO Andreas Lösler , CFO February 2026
Slide 2: Cautionary Note Regarding Forward-Looking Statements
DISCLAIMER CAUTIONARY NOTE REGARDING FORWARD - LOOKING STATEMENTS This presentation contains forward - looking statements about the business, financial condition and earnings performance of the Alzchem Group. These statements are based on assumptions and projections resting upon currently available
Slide 3: Agenda – Roadshow Presentation Q4 2025
AGENDA – ROADSHOW PRESENTATION Q4 2025 I. Company Introduction II. Key Investment Highlights III. Key Financials & Outlook Appendix Detailed Financials Supplementary Company Information
Slide 4: Alzchem is an international chemical company
Alzchem is an international chemical company . The future asks questions. We provide answers. Through brands and products of the highest quality and through sustainable visions for actively shaping global development. © Alzchem Group AG / February 2026
Slide 5: Alzchem at a Glance
ALZCHEM AT A GLANCE Innovative market leader in niche markets since 1908 OUR MARKETS SALES GROWTH EBITDA GROWTH 126 600 116 HEALTH & ANIMAL FINE SAFETY & 562 NUTRITION NUTRITION CHEMISTRY DEFENSE (2) AGRICULTURE RENEWABLE METALLURG Y AUTOM OTIVE ENERGIES (2) (1) (1) © Alzchem Group AG / February 202
Slide 6: Alzchem at a Glance: Production & distribution
ALZCHEM AT A GLANCE Production & distribution - we deliver the world BERLIN (GER) SUNDSVALL (SE) COVENTRY (UK) employees support 1,765 the processes and products of Alzchem with their know- how on a daily TROSTBERG (GER) basis of whom 125 apprentices SCHALCHEN (GER) HART a. d. ALZ (GER) (as of 2025)
Slide 7: Key Share Data
KEY SHARE DATA Share details as of February 25, 2026 SHAREHOLDER SHARES OUTSTANDING 10,176,335 STRUCTURE four two na GmbH 10.14% LAST CLOSING PRICE EUR 161.20 Staluna Trade a. s. MARKET CAPITALIZATION EUR 1,640.43 m 9.20% TICKER ACT Löw SE 6.39% WKN A2YNT3 ISIN DE000A2YNT30 © Alzchem Group AG / Febr
Slide 8: Growth Supported by Global Developments
GROWTH SUPPORTED BY GLOBAL DEVELOPMENTS Highly specialized products supported by lasting megatrends POPULATION GROWTH HEALTHY AGING CLIMATE PROTECTION SAFETY & DEFENSE The world population is Life expectancy is increasing, Energy efficiency and Due to the global political growing steadily and is and
Slide 9: "Verbund" System – Fully Integrated Business Model
“VERBUND” SYSTEM – FULLY INTEGRATED BUSINESS MODEL Ability to adapt production to meet changing end market needs © Alzchem Group AG / February 2026 10
Slide 10: "Verbund" System – Fully Integrated Business Model
“VERBUND” SYSTEM – FULLY INTEGRATED BUSINESS MODEL Ability to adapt production to meet changing end market needs SALES SPLIT OF PRODUCT SEGMENTS 42% 42% 36% Segment 31% 28% Specialty Chemicals Segment Basics & Intermediates 2021 2022 2023 2024 2025 © Alzchem Group AG / February 2026 11
Slide 11: "Verbund" System – Fully Integrated Business Model
“VERBUND” SYSTEM – FULLY INTEGRATED BUSINESS MODEL Ability to adapt production to meet changing end market needs SALES SPLIT OF PRODUCT SEGMENTS 67% 59% 63% Segment 52% 53% Specialty Chemicals Segment Basics & Intermediates 2021 2022 2023 2024 2025 © Alzchem Group AG / February 2026 12
Slide 12: Benefits of "Verbund" System
BENEFITS OF “VERBUND” SYSTEM Competitive advantage and strong barrier to entry Segment Specialty Chemicals OUR BENEFITS Segment Basics & Intermediates • Full control of product quality and specifications • Lower costs • Certainty of supply • Business model based on future technology electricity - no
Slide 13: Health & Nutrition
HEALTH & NUTRITION Single producer of Creatine in western world Premium brand for creatine monohydrate as a food supplement in sports nutrition Dietary supplement with pure creatine Creatine for health & food applications © Alzchem Group AG / February 2026 Did you know ? We are official partner of F
Slide 14: Creatine in Sport, Fitness, Health & Food
CREATINE IN SPORT, FITNESS, HEALTH & FOOD Creatine boosts body energy in many areas © Alzchem Group AG / February 2026 SPORT/PERFORMANCE FITNESS HEALTH FOOD Body Building Body shaping Body vitality Body wellbeing B2B Creapure ® Creavitalis ® B2C Livadur ® 15
Slide 15: Creavitalis goes Food
goes Food Strategic Partnership with Ehrmann brings Creatine to Supermarket Shelves Creatine in Everyday Nutrition – A New Application successfully implemented • Creavitalis ® – premium creatine “Made in Germany” – enters the functional food segment for the first time • Three product categories • Hi
Slide 16: Creatine Capacity Expansion
CREATINE CAPACITY EXPANSION Additional capacity in the sports, food and health sectors Q4 2025 H2 2027 Investment project planning construction commissioning decision and announcement • Total investment: ~ EUR 120 million • Scope: Highly automated production plant for creatine • Strengthening Alzche
Slide 17: Animal Nutrition
ANIMAL NUTRITION Power up your feed – Power up your feed A feed additive for poultry, pigs and other species © Alzchem Group AG / February 2026 19
Slide 18: Patented performance driver in animal nutrition
Patented performance driver in animal nutrition FLEXIBLE FEED FORMULATION APPROACH CREAMINO ® SALES REGION & FORCE GLOBAL 60 Americas 85 EMEA 104 Asia - Pacific © Alzchem Group AG / February 2025 20
Slide 19: Fine Chemicals and Pharma
FINE CHEMICALS AND PHARMA Versatile product range based on dicyandiamide Highly purified form of guanidine salts, diagnostic/pharmaceutical applications Hardeners and accelerators in powder, paste and liquid form DCD FOR Versatile intermediate in various markets METFORMIN including the pharmaceutica
Slide 20: Safety & Defense
SAFETY & DEFENSE Nitroguanidine - versatile power for protection and safety GUANIDINE - Propellant in gas generators in vehicle safety SALTS systems (airbags and seatbelt tensioners), component in pyrotechnic products Intermediate products for defense, agro - chemical products, propellants for airba
Slide 21: Largest Investment in the Company's History
LARGEST INVESTMENT IN THE COMPANY’S HISTORY Alzchem to expand capacities in Germany and starts site selection in US STEP 1 STEP 2 2024 end of 2026 2024 end of 2026 end of 2029 Major raw material for Guanidine Nitrate Nitroguanidine (NQ) Site search Construction • Renew and expand the existing facili
Slide 22: Agenda – Roadshow Presentation Q4 2025
AGENDA – ROADSHOW PRESENTATION Q4 2025 I. Company Introduction II. Key Investment Highlights III. Key Financials & Outlook Appendix Detailed Financials Supplementary Company Information
Slide 23: Key Investment Highlights
KEY INVESTMENT HIGHLIGHTS Leading positions in selected Specialty niche markets supported by global developments Leading market positions in selected niches Strong barriers to entry R&D is a driver of growth © Alzchem Group AG / February 2026 Growth supported by global developments Well positioned t
Slide 24: Leading Market Positions
LEADING MARKET POSITIONS In Selected Niches / Products GLOBAL 1- 9/2025 SELECTED KEY MARKET DESCRIPTION END - MARKETS SEGMENT SPLITS BRANDS POSITION (1) Premium brand for Creatine monohydrate used as Dietary Number 1 supplements in sports nutrition supplement Net Sales CHEMICALS Number 1 A nutrition
Slide 25: Strong Barriers to Entry: Verbund System
STRONG BARRIERS TO ENTRY Protecting margins and creating a high degree of resilience “VERBUND” SYSTEM © Alzchem Group AG / February 2026 27
Slide 26: Strong Barriers to Entry: Brands & Trademarks
STRONG BARRIERS TO ENTRY Protecting margins and creating a high degree of resilience BRANDS & TRADEMARKS © Alzchem Group AG / February 2026 28
Slide 27: Strong Barriers to Entry: Regulation
STRONG BARRIERS TO ENTRY Protecting margins and creating a high degree of resilience REGULATION © Alzchem Group AG / February 2026 29
Slide 28: Strong Barriers to Entry: R&D, IP and Innovation
STRONG BARRIERS TO ENTRY Protecting margins and creating a high degree of resilience R&D, IP AND INNOVATION • Process know - how • Specialisation in carbide based chemicals • R&D activities directed towards Specialty Chemicals • 67 patent families © Alzchem Group AG / February 2026 30
Slide 29: Strong Barriers to Entry
STRONG BARRIERS TO ENTRY Protecting margins and creating a high degree of resilience “VERBUND” SYSTEM BRANDS & TRADEMARKS REGULATION R&D, IP AND INNOVATION • Process know - how © Alzchem Group AG / February 2026 • Specialization in carbide based chemicals • R&D activities directed towards Specialty
Slide 30: Sustainability - Our Path to Climate Neutrality
SUSTAINABILITY - OUR PATH TO CLIMATE NEUTRALITY We take responsibility for people and the environment Our goal: climate neutrality by 2033 (according to Scope 1) ENVIRONMENT • Environmental and climate protection • Sustainable water and waste management • Responsible use of resources SOCIAL • Occupa
Slide 31: Agenda – Roadshow Presentation Q4 2025
AGENDA – ROADSHOW PRESENTATION Q4 2025 I. Company Introduction II. Key Investment Highlights III. Key Financials & Outlook Appendix Detailed Financials Supplementary Company Information
Slide 32: Key Financials
KEY FINANCIALS (1) Development in key figures NET SALES +1% EBITDA +11% EBT +17% DIVIDENDS +10% 18 542 541 554 554 562 116 88 105 105 75 75 +18% 422 +29% 12 379 81 10 11 62 61 48 Ø 11 54 41 8 8 37 27 2020 2021 2022 2023 2024 1- 12 1- 12 2020 2021 2022 2023 2024 1- 12 1- 12 2020 2021 2022 2023 2024 1
Slide 33: Outlook 2026
OUTLOOK 2026 (in M€) Ongoing growth in sales and EBITDA COMMENTS SALES EBITDA • Assumptions growth to approx. • No global recession; stable world economy with raw material and 600.0 M € logistics costs remain at current levels • Electricity prices remain high at 2025 levels growth +7% to approx. • N
Slide 34: Vision & Strategic Target
VISION & STRATEGIC TARGET Our sales and EBITDA goals in the future 1 bn EUR sales 20% EBITDA margin 562 m EUR sales 20% EBITDA margin © Alzchem Group AG Now Future 36
Slide 35: Financial Calendar
FINANCIAL CALENDAR Upcoming dates * FEB 27 2026 Annual Report 2025 MAR 5 2026 Berenberg EU Opportunities Conference London MAR 26 2026 Jefferies Pan - European Mid - Cap Conference London APR 30 2026 Quarterly Statement 1st Quarter 2026 MAY 5 2026 Annual General Meeting 2026 MAY 21 2026 Berenberg Eu
Slide 36: Feedback
FEEDBACK We appreciate your feedback Were your expectations met? Are you missing any content ? WE APPRECIATE YOUR FEEDBACK! Link QR - Code © Alzchem Group AG / February 2025 38
Slide 37: Agile Science Pure Results
Alzchem Group AG Investor Relations T +49 8621 86 - 2888 AGILE SCIENCE ir@alzchem.com PURE RESULTS www.alzchem.com
Slide 38: Executive Team
EXECUTIVE TEAM Alzchem Group AG DR. JÜRGEN SANS , COO ANDREAS NIEDERMAIER, CEO WITH ALZCHEM SINCE 1998 WITH ALZCHEM SINCE 1999 AREAS OF RESPONSIBILITY AREAS OF RESPONSIBILITY Production & Technology, Corporate Strategy , Revision, Engineering, Environmental Innovation Management, Risk Management, Pr
Slide 39: Our History
OUR HISTORY Innovative since 1908 Commissioning of Creamino ® and Founding of the Listing of SKW Acquisition of NITRALZ ® production Continuous Bayerische Stickstoff - Trostberg AG as Founding of the Nordic expansions increase in Werke AG in Munich a public company Alzchem Group Carbide AB (appr. 60
Slide 40: Our Products and Markets
OUR PRODUCTS AND MARKETS Successful with proven and new products in various industries MAIN PRODUCTS DESCRIPTION END - MARKETS A nutritional additive for poultry and pigs Feed additive Creapure ® , premium brand for creatine monohydrate as ingredient in sports & health nutrition Food supplements Die
Slide 41: Our Products and Markets
OUR PRODUCTS AND MARKETS Successful with proven and new products in various industries MAIN PRODUCTS DESCRIPTION END - MARKETS Calcium carbide - based mixtures for hot metal desulphurization Steel industry Propellants for airbags, safety systems, component in pyrotechnic products Automotive INTERMED